// App-Quantinova.ai

ABS047 : ANNUAL BLEEDS (AB) AND HEALTH‐RELATED QUALITY OF LIFE (HRQOL) AMONG ADULTS WITH HAEMOPHILIA A (HA) RECEIVING PROPHYLAXIS

Researchers

Presenter

  • L. Young

Principal Investigators

  • L. Markson

  • L. Chi

  • J. Alvir

  • Y. Chen

  • A. Unuigbe

  • T. Burke

  • I. Winburn

Medical Centers

  • Pfizer Limited, Surrey, United Kingdom

  • Pfizer Inc, Collegeville, PA

  • Pfizer Inc, New York, NY

  • University of Washington, Seattle, WA, United States

  • HCD Economics, Daresbury

  • Pfizer Oncology, Surrey, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved